Marker Therapeutics (MRKR) Prepaid Assets (2010 - 2026)
Marker Therapeutics (MRKR) posted quarterly Prepaid Assets of $418053.0 for Q1 2026, down 50.31% year-over-year from $841293.0 in Q1 2025, and down 36.54% quarter-over-quarter from $658750.0 in Q4 2025.
Marker Therapeutics (MRKR) Prepaid Assets (2010 - 2026) Analysis & Trends
Marker Therapeutics (MRKR) has reported Prepaid Assets for 16 consecutive years, with $418053.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 50.31% year-over-year to $418053.0; the TTM figure through Mar 2026 stood at $418053.0 (down 50.31% YoY), while the FY2025 annual figure was $658750.0, up 36.19% from the prior year.
- Prepaid Assets eased to $418053.0 in Q1 2026 per MRKR's latest filing, from $658750.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $2.8 million in Q2 2022 and bottomed at $418053.0 in Q1 2026.
- Historically, Prepaid Assets has averaged $1.5 million across 5 years, with a median of $1.3 million in 2025.
- Annual changes were most pronounced in 2024 — Prepaid Assets sank 62.24% — and 2025, when it jumped 36.19%.
- Marker Therapeutics' Prepaid Assets stood at $1.8 million in 2022, then tumbled by 46.57% to $988126.0 in 2023, then plunged by 51.05% to $483717.0 in 2024, then jumped by 36.19% to $658750.0 in 2025, then plunged by 36.54% to $418053.0 in 2026.
- Business Quant data shows MRKR's Prepaid Assets at $418053.0 in Q1 2026, $658750.0 in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Marker Therapeutics | 27.04 Mn | 15.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 418,053.00 |
| Dec 31, 2025 | 658,750.00 |
| Sep 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 841,293.00 |
| Dec 31, 2024 | 483,717.00 |
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 917,009.00 |
| Dec 31, 2023 | 988,126.00 |
| Sep 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | 2.09 Mn |
| Mar 31, 2023 | 2.43 Mn |
| Dec 31, 2022 | 1.85 Mn |
| Sep 30, 2022 | 2.67 Mn |
| Jun 30, 2022 | 2.83 Mn |
| Mar 31, 2022 | 2.20 Mn |
| Dec 31, 2021 | 2.48 Mn |
| Sep 30, 2021 | 2.70 Mn |
| Jun 30, 2021 | 2.80 Mn |